Khosrovi Behzad 4/A
4/A · NovaBay Pharmaceuticals, Inc. · Filed Nov 15, 2010
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2007-12-14+37,500→ 237,500 totalExercise: $3.56From: 2008-12-14Exp: 2017-12-13→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]Original Form 4 filed on December 18, 2007. This amended form is being filed to correct the total securities following reported transaction under Table II, Item 9 which should be 237,500 not 37,500.